Drug companies face clampdown on trial results
Leading medical journals have formed an alliance to block publication of the results of drug trials that they believe have been distorted by pressure from pharmaceutical
Leading medical journals have formed an alliance to block publication of the results of drug trials that they believe have been distorted by pressure from pharmaceutical